Scienture Holdings (SCNX) FCF Margin (2013 - 2026)
Scienture Holdings' (SCNX) quarterly FCF Margin came in at 911.52% in Q2 2026, up 82.41% quarter-over-quarter from 5182.88% in Q1 2026.
Analysis
Scienture Holdings (SCNX) FCF Margin (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed FCF Margin across 14 years of filings, most recently posting 911.52% for Q2 2026.
- In Q2 2026, FCF Margin changed N/A year-over-year to 911.52%; the TTM figure through Jun 2026 stood at 2691.79% (down 293385.0% YoY), while the FY2025 annual figure was 3100.6%, up 734797.0% from the prior year.
- FCF Margin came in at 911.52% for Q2 2026 at Scienture Holdings, up from 5182.88% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 22578.51% in Q2 2024 to a low of 28820.99% in Q1 2025.
- Average FCF Margin over 5 years is 1063.58%, with a median of 37.96% recorded in 2022.
- Year-over-year, FCF Margin slumped 24522 bps in 2023 and jumped 2363811 bps in 2026.
- Over 5 years, FCF Margin stood at 32.28% in 2022, then slumped by 430 bps to 106.48% in 2023, then soared by 21304 bps to 22578.51% in 2024, then slumped by 228 bps to 28820.99% in 2025, then surged by 97 bps to 911.52% in 2026.
- Per Business Quant data, the three most recent FCF Margin figures were 911.52% in Q2 2026, 5182.88% in Q1 2026, and 28820.99% in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | 7.41% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 8.76% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 3.10% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | -6.52% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 20.79% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 20.15% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | 14.76% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 23.24% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | - |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | -911.52% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -911.52% |
| Mar 31, 2026 | -5,182.88% |
| Mar 31, 2025 | -28,820.99% |
| Jun 30, 2024 | 22,578.51% |
| Dec 31, 2023 | -106.48% |
| Sep 30, 2023 | 2.59% |
| Jun 30, 2023 | 27.04% |
| Mar 31, 2023 | -275.40% |
| Dec 31, 2022 | 32.28% |
| Sep 30, 2022 | -30.70% |
| Jun 30, 2022 | -45.23% |
| Mar 31, 2022 | -30.18% |
| Dec 31, 2021 | -17.87% |
| Sep 30, 2021 | -28.94% |
| Jun 30, 2021 | -36.41% |
| Mar 31, 2021 | -23.26% |
| Dec 31, 2020 | -36.58% |
| Sep 30, 2020 | 39.22% |
| Jun 30, 2020 | -54.18% |
| Mar 31, 2020 | -19.71% |